Premenstrual syndrome
Also known as: PMS
Medically reviewed by Hormone Journal Editorial Team · Last reviewed 2026-05-22
Premenstrual syndrome (PMS) is a recurrent cluster of physical and emotional symptoms affecting up to 75–80% of menstruating women in the luteal phase, resolving within days of menstruation starting.
What it is
Premenstrual syndrome (PMS) affects an estimated 75–80% of menstruating women at some point in their reproductive lives, with 20–40% reporting symptoms disruptive enough to interfere with daily functioning. Also called premenstrual syndrome or PMS, it is a recurrent, predictable pattern of physical, emotional, and behavioural symptoms that emerge during the luteal phase — typically 5 to 11 days before menstruation — and resolve within a few days of the period starting. A global pooled prevalence analysis places the figure at 47.8% of reproductive-age women experiencing clinically significant PMS worldwide (StatPearls / NIH, 2023).
PMS exists on a spectrum. At its milder end it causes manageable monthly discomfort. At its severe end it merges with premenstrual dysphoric disorder (PMDD), a recognized psychiatric diagnosis under DSM-5 that affects roughly 3–8% of menstruating women and requires more intensive treatment. Understanding PMS as hormonally driven, cyclical, and treatable matters for Canadian patients: many women normalize their symptoms for years before seeking care, and effective options — from lifestyle changes to prescription SSRIs — are accessible through family physicians, nurse practitioners, and virtual care platforms across every province.
Causes and mechanism
PMS is not caused by abnormally low hormone levels. It arises from the brain's sensitivity to normal hormonal fluctuations during the luteal phase. Several mechanisms are involved:
- Progesterone and allopregnanolone. After ovulation, rising and then falling progesterone alters GABA receptor activity and serotonin signalling, affecting mood, sleep, and anxiety.
- Serotonin sensitivity. Estrogen and progesterone fluctuations reduce serotonin availability and receptor responsiveness, contributing to irritability, food cravings, and low mood.
- Prostaglandins. Elevated prostaglandin production in the late luteal phase drives cramping, bloating, breast tenderness, and headaches.
- Fluid regulation. Progesterone-related shifts in the renin-angiotensin-aldosterone system promote fluid retention and abdominal bloating.
Several factors amplify symptom severity: low dietary calcium, magnesium, or vitamin B6; chronic stress; high caffeine or alcohol intake; and a sedentary lifestyle. Regular aerobic exercise has a documented moderating effect on PMS across multiple studies.
Symptoms and diagnosis
Symptoms must occur in the luteal phase and resolve after menstruation begins — that cyclical timing is what distinguishes PMS from general mood or fatigue problems.
| Domain | Common symptoms |
|---|---|
| Physical | Bloating, breast tenderness, headaches, fatigue, joint/muscle aches, acne flares, appetite changes, sleep disturbance |
| Emotional | Irritability, mood swings, tearfulness, anxiety, low confidence |
| Behavioural | Difficulty concentrating, social withdrawal, food cravings |
Diagnosis is clinical. Formal criteria require at least one physical and one psychological symptom in the 5 days before menstruation, resolving within 4 days of onset, confirmed across at least 3 consecutive cycles. Prospective symptom charting — a daily diary kept for 2 to 3 cycles — is the most reliable confirmation tool and is worth bringing to any appointment. TSH testing is useful to rule out thyroid dysfunction, which can worsen premenstrual symptoms and is common in Canadian women.
Treatment options
Most women benefit from a stepped approach: lifestyle measures first, then supplements, then prescription therapy if needed.
Lifestyle (first-line for mild to moderate PMS) Regular aerobic exercise is one of the most consistently effective interventions across the evidence base. Dietary adjustments — reducing caffeine, alcohol, salt, and refined sugar; eating smaller, more frequent meals; increasing complex carbohydrates in the luteal phase — also reduce symptom burden. Adequate sleep and stress management support both mood and physical symptoms.
Nutritional supplements with clinical evidence
- Calcium 1,000–1,200 mg/day: among the best-studied supplements for PMS, with randomized trial evidence for reducing both mood and physical symptoms.
- Magnesium 200–400 mg/day: evidence for reducing fluid retention and mood symptoms.
- Vitamin B6 50–100 mg/day: some evidence for irritability and mood.
- Vitex agnus-castus (chasteberry): evidence for breast tenderness and mood changes, though study quality varies.
Prescription options
- SSRIs (sertraline, fluoxetine): effective for predominantly psychological symptoms; can be taken continuously or only during the luteal phase. Available by prescription from a family physician or through virtual care services such as Felix, Maple, or Cleo.
- Combined oral contraceptive pill: suppresses ovulation and the hormonal fluctuations driving PMS; most useful when contraception is also desired.
- NSAIDs (ibuprofen, naproxen): for cramping, headaches, and musculoskeletal pain; available over the counter at Canadian pharmacies.
- Spironolactone: for significant fluid retention not responding to dietary measures.
- GnRH analogues: reserved for severe, treatment-resistant PMS or PMDD.
When to see a clinician in Canada
See a family physician, nurse practitioner, or gynaecologist if:
- Premenstrual symptoms are significantly affecting your work, relationships, or daily activities
- Symptoms have worsened over time or are primarily severe psychological symptoms (which may indicate PMDD)
- Lifestyle changes have not provided adequate relief after 2–3 cycles
- You want to rule out thyroid dysfunction or another hormonal condition
Bring a symptom diary covering at least 2 cycles — it will help your clinician confirm the cyclical pattern and choose the most appropriate treatment. In provinces where virtual care is covered under provincial health plans (Ontario, British Columbia, Alberta, and others), platforms such as Maple or Felix can facilitate an initial assessment and prescription without an in-person visit.
Limitations and open questions
Research is still emerging on several aspects of PMS. The precise neurobiological mechanism linking progesterone metabolites to GABA receptor sensitivity is not fully characterized, and it remains unclear why some women are far more sensitive to normal hormonal fluctuations than others. Evidence for many nutritional supplements — including chasteberry and vitamin D — comes from trials with small sample sizes or short follow-up periods, and Health Canada has not issued specific guidance on supplement use for PMS. The optimal SSRI dosing strategy (continuous versus luteal-phase-only) has not been definitively settled for all symptom profiles. There is also limited Canadian-specific prevalence data; most figures cited in clinical practice are drawn from international studies. Women with comorbid depression, anxiety, or perimenopause may find that PMS symptoms overlap with or amplify those conditions in ways that are not yet well-studied.
FAQs
Is PMS the same as PMDD?
No. PMS and PMDD share the same cyclical timing but differ significantly in severity. PMS causes mild to moderate monthly discomfort that most women can manage with lifestyle changes. PMDD causes severe psychological symptoms — extreme mood swings, depression, and anxiety — that substantially impair relationships and daily functioning, and it is classified as a psychiatric disorder under DSM-5. Roughly 3–8% of menstruating women meet criteria for PMDD, compared with the 20–40% who experience functionally significant PMS. PMDD typically requires prescription treatment, most often SSRIs or hormonal suppression.
Can PMS be caused by low progesterone?
This is a widely held belief, but the evidence does not consistently support it. Women with PMS do not reliably have lower progesterone levels than those without PMS. Current understanding points to an abnormal sensitivity of the brain's serotonin and GABA systems to normal progesterone fluctuations, rather than a progesterone deficiency. Some women do report benefit from luteal-phase progesterone supplementation, possibly through effects on neurosteroid pathways, but randomized trial evidence for this approach is limited and mixed.
Does the contraceptive pill cure PMS?
The combined oral contraceptive pill can significantly reduce or eliminate PMS by suppressing ovulation and the hormonal fluctuations that drive symptoms, and it works well for many women. However, it does not work equally for everyone — a minority of women experience worsening mood or new-onset low mood on certain formulations, particularly those containing progestogens with higher androgenic activity. Finding the right pill often requires some trial and adjustment with a prescribing clinician. It is not a cure in the sense of permanently resolving PMS; symptoms typically return if the pill is stopped.
How is PMS different from just feeling tired or moody?
The defining feature of PMS is its predictable, cyclical relationship to the menstrual cycle. If symptoms appear consistently in the 5 to 11 days before menstruation and reliably resolve within 4 days of the period starting, that pattern points to PMS rather than general fatigue or mood variability. Tracking symptoms daily across 2 to 3 cycles is the most reliable way to confirm whether a hormonal pattern is present — formal diagnostic criteria require this prospective charting before a PMS diagnosis is made.
Are PMS treatments covered under Canadian provincial drug plans?
Coverage varies by province and by treatment type. SSRIs such as sertraline and fluoxetine are listed on most provincial formularies (including Ontario's ODB and BC PharmaCare) when prescribed for an eligible indication, though PMS-specific coverage criteria differ. Combined oral contraceptives are covered under some provincial plans and most employer drug benefits. Over-the-counter options — ibuprofen, calcium, magnesium — are not covered by provincial drug plans but are widely available at low cost. Patients should confirm coverage with their provincial formulary or benefits provider, as listing status changes periodically.
Sources
- Premenstrual Syndrome – StatPearls, NIH National Library of Medicine
- Premenstrual Syndrome: Symptoms and Causes – Mayo Clinic
- Premenstrual Syndrome and Premenstrual Dysphoric Disorder – American Family Physician
- Herbal treatments for alleviating premenstrual symptoms – Journal of Psychosomatic Obstetrics and Gynaecology
- PMS (premenstrual syndrome) – NHS
- Premenstrual syndrome: new insights into etiology and review of management – PMC / NIH